NVRO - NEVRO CORP ()

NVROのニュース

   Why the Service Neuroendoscopy Devices Market is set to explode? Top Companies: Nevro Corporation, Ackermann Instrumente GmbH, Adeor medical AG, B. Braun Aesculap  2021/09/01 07:14:42 OpenPR
Neuroendoscopy Devices Market Size | 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2028 is latest study published by Fortune Business Insights. The Global
   Implantable Neurostimulation Devices Market Covering Growth Elements and Future Trends by 2027, Players - LivaNova, Nevro, NeuroPace, Beijing Pins, Synapse Biomedical, St. Jude Medical (Abbott)  2021/08/27 12:25:32 OpenPR
The Implantable Neurostimulation Devices Market is expected to grow at a CAGR of 6.1 % and is poised to reach $XX Billion by 2027 as compared to $XX Billion in 2020 The research report on the Implantable Neurostimulation Devices Market fabricated
   Spinal Cord Stimulation System Market Marvelous Growth with Fantastic Rate During the Forecast Period with Key Players - Boston Scientific, Nevro, Spinal Modulation.  2021/08/25 12:51:35 OpenPR
The Spinal Cord Stimulation System Market is expected to grow at a CAGR of 8.9%. The factors leading to this extraordinary growth is attributed to various market dynamics discussed in the report. Our experts have examined the market from a
   Bridger Management, Llc Buys Centene Corp, Nevro Corp, Post Holdings Partnering Corp, Sells HCA ...  2021/08/24 20:38:21 GuruFocus
Related Stocks: CLVT , QTRX , DXCM , CNC , NVRO , PSPC.U , LIVN , CHFW.U , NEXI , MSFT , FCNCA , DRNA , SQZ , DMTK ,
   Nevro Corp (NVRO): Price Down $-3.45 (-3.13)% Over Past Day, Down $-0.25 (-0.23)% Over Past Hour  2021/08/18 15:18:43 ETF Daily News
This is a reversal of the price action on the previous day, in which price moved up. The post Nevro Corp (NVRO): Price Down $-3.45 (-3.13)% Over Past Day, Down $-0.25 (-0.23)% Over Past Hour appeared first on ETF Daily News .
   Here is What Hedge Funds Think About Nevro Corp (NVRO)  2021/07/06 15:37:57 Insider Monkey
   Insights on the Pain Management Devices Global Market to 2026 - Key Motivators, Restraints and Opportunities  2021/07/02 08:53:00 Intrado Digital Media
Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "Global Pain Management Devices Market 2020-2026" report has been added to ResearchAndMarkets.com''s offering. The global pain management devices market is growing at a considerable CAGR of 7.3% during the forecast period (2021-2027). The increasing prevalence of chronic diseases along with the easy availability of technically advanced pain management devices in the market are the key factors to drive the growth of the global pain management devices market. Supportive reimbursement policies and adverse effects of pain medications are some other factors that are contributing to the growth of the market. However, certain factors are affecting the growth of the market. The high cost of pain management devices, lack of awareness regarding the availability of pain management devices, insufficiency of a pain specialist in underdeveloped and some emerging economies are some key factors that may restrain the growth of the pain management devices market globally.
   A Look Into Nevro''s Debt  2021/06/28 13:17:33 Benzinga
Over the past three months, shares of Nevro (NYSE: NVRO ) increased by 18.38%. Before having a look at the importance of debt, let us look at how much debt Nevro has. Nevro''s Debt Based on Nevro''s financial statement as of May 5, 2021, long-term debt is at $144.04 million and current debt is at $171.00 million, amounting to $315.03 million in total debt. Adjusted for $86.54 million in cash-equivalents, the company''s net debt is at $228.50 million. Let''s define some of the terms we used in the paragraph above. Current debt is the portion of a company''s debt which is due within 1 year, while long-term debt is Full story available on Benzinga.com
   Pain Management Devices Market Value to Increase by US$ 8,388.67 million in the Forecast Period 2021-2028 At A Rate (CAGR) Of 8.1% with Top Companies Like Halyard Health, Inc, B. Braun Melsungen AG, Neurotech NA, Inc., and Nevro Corp.  2021/06/23 19:32:10 OpenPR
Pain management devices are used for managing or controlling the pain caused due to medical conditions like arthritis, injury, cancer, and others. Devices for pain management are used according to the severity of the pain; these devices are widely used
   Nevro Announces SENZA-PDN Clinical Data Presentation at the American Diabetes Association 81st Scientific Sessions  2021/06/22 10:00:00 PR Newswire
REDWOOD CITY, Calif., June 22, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that data from the SENZA Painful Diabetic Neuropathy (PDN) Randomized
   Spinal Cord Stimulation Devices Market Outlook, Industry Size, Market Share, Forecast Till 2028 | Boston, Scientific and corporation, Medtronic plc, Nevro corp  2021/03/04 12:43:28 OpenPR
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Spinal Cord Stimulation Devices Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. The Spinal Cord Stimulation Devices Market is expected to witness growth in upcoming years due to factors such as
   Nevro (NYSE:NVRO) Announces Quarterly Earnings Results  2021/02/26 18:24:41 Transcript Daily
Nevro (NYSE:NVRO) announced its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.21) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.33) by $0.12, MarketWatch Earnings reports. Nevro had a negative return on equity of 30.25% and a negative net margin of 24.46%. Shares of Nevro stock […]
   Nevro Reports Fourth Quarter and Full Year 2020 Financial Results  2021/02/24 21:05:00 PR Newswire
REDWOOD CITY, Calif., Feb. 24, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported its financial results for the fourth quarter and full year ended December…
   Nevro to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference  2021/02/01 12:00:00 PR Newswire
REDWOOD CITY, Calif., Feb. 1, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present…
   Nevro to Report Fourth Quarter and Full-Year 2020 Financial Results  2021/01/27 12:00:00 PR Newswire
REDWOOD CITY, Calif., Jan. 27, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report its financial results for the fourth quarter…

calendar